Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, A. W.
Right arrow Articles by Metcalf, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, A. W.
Right arrow Articles by Metcalf, D.

Stem Cells, Vol 13, 512-516, Copyright © 1995 by AlphaMed Press


ORIGINAL ARTICLES

Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy

AW Roberts, E DeLuca, CG Begley, R Basser, AP Grigg and D Metcalf
Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.

The elevated white cell counts (WCC) and myeloid progenitor cell levels in the blood induced by granulocyte colony-stimulating factor (G-CSF) treatment were studied in three settings: cancer patients previously treated with chemo/radiotherapy (n = 13), untreated cancer patients (n = 5) and normal volunteers (n = 9). The inter-individual variations in progenitor cell mobilization responses to G-CSF and the impact of previous chemo/radiotherapy were investigated. The absolute levels of circulating progenitor cells, but not total white cells, were reduced significantly in the pretreated cancer patients (median 961, range 289- 3355 per ml blood) as compared to untreated cancer patients (median 9891, range 2219-16625 per ml blood). In each setting, wide ranges of circulating progenitor cell numbers were observed, and the variation in progenitor cell numbers was considerably greater than observed for the WCC. However, progenitor cell numbers in normal volunteers (942-25296 per ml blood) demonstrated as much variance as observed in pretreated cancer patients. This broad physiological variation in progenitor cell levels induced by G-CSF needs to be considered when designing strategies for allogeneic peripheral blood stem cell transplantation.


This article has been cited by other articles:


Home page
Stem CellsHome page
M. Abraham, K. Biyder, M. Begin, H. Wald, I. D. Weiss, E. Galun, A. Nagler, and A. Peled
Enhanced Unique Pattern of Hematopoietic Cell Mobilization Induced by the CXCR4 Antagonist 4F-Benzoyl-TN14003
Stem Cells, September 1, 2007; 25(9): 2158 - 2166.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. E. Broxmeyer, C. M. Orschell, D. W. Clapp, G. Hangoc, S. Cooper, P. A. Plett, W. C. Liles, X. Li, B. Graham-Evans, T. B. Campbell, et al.
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
J. Exp. Med., April 18, 2005; 201(8): 1307 - 1318.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Abkowitz, A. E. Robinson, S. Kale, M. W. Long, and J. Chen
Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure
Blood, August 15, 2003; 102(4): 1249 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Kronenwett, S. Martin, and R. Haas
The Role of Cytokines and Adhesion Molecules for Mobilization of Peripheral Blood Stem Cells
Stem Cells, September 1, 2000; 18(5): 320 - 330.
[Abstract] [Full Text]


Home page
BloodHome page
G. de Haan, S. J. Szilvassy, T. E. Meyerrose, B. Dontje, B. Grimes, and G. Van Zant
Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers
Blood, August 15, 2000; 96(4): 1374 - 1379.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.G. Begley, R. Basser, R. Mansfield, B. Thomson, W.R.L. Parker, J. Layton, B. To, J. Cebon, W.P. Sheridan, R.M. Fox, et al.
Enhanced Levels and Enhanced Clonogenic Capacity of Blood Progenitor Cells Following Administration of Stem Cell Factor Plus Granulocyte Colony-Stimulating Factor to Humans
Blood, November 1, 1997; 90(9): 3378 - 3389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. L. Basser, J. E.J. Rasko, K. Clarke, J. Cebon, M. D. Green, A. P. Grigg, J. Zalcberg, B. Cohen, J. O'Byrne, D. M. Menchaca, et al.
Randomized, Blinded, Placebo-Controlled Phase I Trial of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor With Filgrastim After Dose-Intensive Chemotherapy in Patients With Advanced Cancer
Blood, May 1, 1997; 89(9): 3118 - 3128.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. E.J. Rasko, E. O'Flaherty, and C. G. Begley
Mpl Ligand (MGDF) Alone and in Combination with Stem Cell Factor (SCF) Promotes Proliferation and Survival of Human Megakaryocyte, Erythroid and Granulocyte/Macrophage Progenitors
Stem Cells, January 1, 1997; 15(1): 33 - 42.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1995 by AlphaMed Press.